Capsules
KPV Capsules
250 mcg × 100 capsules · capsule form
$165.00 CAD
KPV capsules supplied for research-use catalogue ordering.
- CAS number
- 67727-97-3
- Current lot #
For laboratory and research use only - not for human consumption.
Latest lab results
Latest lab results
Checking the live COA archive for the newest lot documentation.
Previous lab results
Trace every archived lot result.
Use the verification archive to select a peptide name and review all published lot records alphabetically.
View previous lab resultsAbout this compound
This capsule listing uses the same KPV research information as the vial listing, with capsule-specific quantity and order details.
What it has been researched for
KPV is studied as a tool for anti-inflammatory signalling in gut and tissue research models.
How it is thought to work
Research indicates KPV can be transported by PepT1 and studied in inflammatory-signalling models.
Regulatory status
KPV is not an approved medicine in any jurisdiction, and this product is supplied as a research compound only. In July 2026 a US FDA advisory committee voted 8-6-1 to recommend KPV for the American 503A compounding list, having reviewed it for wound healing and inflammatory conditions and against the recommendation of the FDA's own scientific reviewers. That vote is advisory and not binding: it concerns what US compounding pharmacies may work with, it is not a drug approval, and it takes effect only if the FDA accepts it and completes formal rulemaking.
Product details
One capsule container with 100 capsules at 250 mcg per capsule.